Estrogens maintain bile duct mass and reduce apoptosis after biliodigestive anastomosis in bile duct ligated rats

Journal of Hepatology

Volumn 44, Issue 6, 2006, Pages 1158-1166

  Svegliati Baroni, Gianluca ^a   Ghiselli, Roberto ^a   Marzioni, Marco ^a   Alvaro, Domenico ^b   Mocchegiani, Federico ^a   Saccomanno, Stefania ^a   Sisti, Valerio ^a   Ugili, Laura ^a   Orlando, Fiorenza ^c   Alpini, Gianfranco ^d   Saba, Vittorio ^a   Benedetti, Antonio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c INRCA   (Italy)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Cholangiocyte; Cholestasis; Proliferation

Indexed keywords

ESTRADIOL; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT; BILE DUCT BYPASS; BILE DUCT DISEASE; BILE DUCT LIGATION; BILE DUCT MALFORMATION; CELL PROLIFERATION; CHOLANGIOCYTE; CONTROLLED STUDY; DUCTOPENIA; EPITHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; APOPTOSIS; BILE DUCT DISEASES; BILE DUCTS; BODY WEIGHT; CELL PROLIFERATION; ESTRADIOL; ESTROGENS; LIVER; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; ORGAN SIZE; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR;

EID: 33646156160     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.10.032     Document Type: Article

References (33)

1. Alpini G., McGill J.M., and Larusso N.F. The pathobiology of biliary epithelia. Hepatology 35 (2002) 1256-1268
2. Alvaro D., Gigliozzi A., and Attili A.F. Regulation and deregulation of cholangiocyte proliferation. J Hepatol 33 (2000) 333-340
3. Boyer JL. Vanishing bile duct syndrome-from bench to bed side; 1997. p. 240-246.
4. Alvaro D. Biliary epithelium: a new chapter in cell biology. Ital J Gastroenterol Hepatol 31 (1999) 78-83
5. Alvaro D., Alpini G., Onori P., Franchitto A., Glaser S., Le Sage G., et al. Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology 123 (2002) 336-344
6. Alvaro D., Onori P., Metalli V.D., Svegliati-Baroni G., Folli F., Franchitto A., et al. Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology 36 (2002) 297-304
7. Jones D.E. Pathogenesis of primary biliary cirrhosis. J Hepatol 39 (2003) 639-648
8. Alvaro D., Alpini G., Onori P., Franchitto A., Glaser S.S., Le Sage G., et al. Alfa and beta estrogen receptors and the biliary tree. Mol Cell Endocrinol 193 (2002) 105-108
9. Gigliozzi A., Alpini G., Baroni G.S., Marucci L., Metalli V.D., Glaser S.S., et al. Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology 127 (2004) 1198-1209
10. Chen J., Robertson G., Field J., Liddle C., and Farrell G.C. Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats. Hepatology 28 (1998) 624-630
11. Desmet V.J., van Eyken P., and Roskams T. Histopathology of vanishing bile duct diseases. Adv Clin Path 2 (1998) 87-99
12. Invernizzi P., Alvaro D., Crosignani A., Gaudio E., and Podda M. Tamoxifen in treatment of primary biliary cirrhosis. Hepatology 39 (2004) 1175-1176
13. Alvaro D., Alpini G., Onori P., Perego L., Svegliata Baroni G., Franchitto A., et al. Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. Gastroenterology 119 (2000) 1681-1691
14. Baroni G.S., D'Ambrosio L., Curto P., Casini A., Mancini R., Jezequel A.M., et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23 (1996) 1189-1199
15. LeSage G.D., Benedetti A., Glaser S., Marucci L., Tretjak Z., Caligiuri A., et al. Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. Hepatology 29 (1999) 307-319
16. Natori S., Rust C., Stadheim L.M., Srinivasan A., Burgart L.J., and Gores G.J. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 34 (2001) 248-253
17. Alpini G., Lenzi R., Sarkozi L., and Tavoloni N. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest 81 (1988) 569-578
18. LeSage E.G., Alvaro D., Benedetti A., Glaser S., Marucci L., Baiocchi L., et al. Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. Gastroenterology 117 (1999) 191-199
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
20. Svegliati-Baroni G., Ridolfi F., Caradonna Z., Alvaro D., Marzioni M., Saccomanno S., et al. Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosis. J Hepatol 39 (2003) 528-537
21. Marzioni M., LeSage G., Glaser S., Patel T., Marienfeld C., Ueno Y., et al. Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct ligated rats. Am J Physiol 284 (2003) G837-G852
22. Alvaro D, Invernizzi P, Onori P, Franchitto A, De Santis A, Crosignani A, et al. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 2004;41: 905-912.
23. Zimmermann H., Reichen J., Zimmermann A., Sagesser H., Thenisch B., and Hoflin F. Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat. Gastroenterology 103 (1992) 579-589
24. Desmet V., Roskams T., and Van Eyken P. Ductular reaction in the liver. Pathol Res Pract 191 (1995) 513-524
25. Desmet V, Roskams T, Van Eyken P. Pathology of the biliary tree in cholestasis: ductular reaction; 1998. p. 143-54.
26. Nakanuma Y., Tsuneyama K., Sasaki M., and Harada K. Destruction of bile ducts in primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 14 (2000) 549-570
27. Nakanuma Y., Tsuneyama K., and Harada K. Pathology and pathogenesis of intrahepatic bile duct loss. J Hepatobiliary Pancreat Surg 8 (2001) 303-315
28. Harada K., Furubo S., Ozaki S., Hiramatsu K., Sudo Y., and Nakanuma Y. Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis. J Hepatol 34 (2001) 500-506
29. Tinmouth J., Lee M., Wanless I.R., Tsui F.W., Inman R., and Heathcote E.J. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 22 (2002) 228-234
30. Kuroki T., Seki S., Kawakita N., Nakatani K., Hisa T., Kitada T., et al. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 429 (1996) 119-129
31. Vierling J.M. Primary biliary cirrhosis and autoimmune cholangiopathy. Clin Liver Dis 8 (2004) 177-194
32. Kita H., Nalbandian G., Keeffe E.B., Coppel R.L., and Gershwin M.E. Pathogenesis of primary biliary cirrhosis. Clin Liver Dis 7 (2003) 821-839
33. Reddy A., Prince M., James O.F., Jain S., and Bassendine M.F. Tamoxifen: a novel treatment for primary biliary cirrhosis?. Liver Int 24 (2004) 194-197